Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists-Reference-Cited by-同舟云学术

Benzimidazoles as benzamide replacements within cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists

Published:2012-10 Issue:19 Volume:22 Page:6181-6184
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Cherney Robert J.,Mo Ruowei,Meyer Dayton T.,Pechulis Anthony D.,Guaciaro Michael A.,Lo Yvonne C.,Yang Gengjie,Miller Persymphonie B.,Scherle Peggy A.,Zhao Qihong,Cvijic Mary Ellen,Barrish Joel C.,Decicco Carl P.,Carter Percy H.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. Monocyte Chemoattractant Protein-1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and Controversies

2. The CCR2 receptor as a therapeutic target

3. Chemokine inhibition in inflammatory arthritis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly functionalized heterogeneous dendrigraft catalysts with peripheral copper moieties for the facile synthesis of 2-substituted benzimidazoles and 2,2-disubstituted benzimidazoles;RSC Advances;2016

2. Efficient domino synthesis of benzimidazole derivatives: copper catalysis versus transition metal-free conditions;Tetrahedron Letters;2015-03

3. Selective and Dual Targeting of CCR2 and CCR5 Receptors: A Current Overview;Topics in Medicinal Chemistry;2014

4. Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 – 2012;Expert Opinion on Therapeutic Patents;2013-02-22